Peter Fayers

42.7k total citations · 15 hit papers
281 papers, 29.8k citations indexed

About

Peter Fayers is a scholar working on Oncology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Peter Fayers has authored 281 papers receiving a total of 29.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Oncology, 67 papers in Economics and Econometrics and 61 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Peter Fayers's work include Cancer survivorship and care (70 papers), Health Systems, Economic Evaluations, Quality of Life (66 papers) and Childhood Cancer Survivors' Quality of Life (38 papers). Peter Fayers is often cited by papers focused on Cancer survivorship and care (70 papers), Health Systems, Economic Evaluations, Quality of Life (66 papers) and Childhood Cancer Survivors' Quality of Life (38 papers). Peter Fayers collaborates with scholars based in United Kingdom, Norway and Netherlands. Peter Fayers's co-authors include David Machin, Andrew Bottomley, Stein Kaasa, Edward R. Tufte, Kristin Bjordal, Neil K. Aaronson, Marianne Jensen Hjermstad, Desmond Curran, Mirjam A. G. Sprangers and M. Groenvold and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Peter Fayers

278 papers receiving 28.7k citations

Hit Papers

EORTC QLQ-C30 Scoring Manual 1990 2026 2002 2014 1995 2011 1990 2007 1999 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Fayers United Kingdom 79 8.9k 6.4k 5.7k 5.2k 4.8k 281 29.8k
Monika Bullinger Germany 70 8.2k 0.9× 4.9k 0.8× 5.2k 0.9× 6.0k 1.2× 4.4k 0.9× 304 34.1k
Marianne Sullivan Sweden 65 9.5k 1.1× 6.1k 1.0× 8.5k 1.5× 3.2k 0.6× 4.4k 0.9× 145 32.8k
Mirjam A. G. Sprangers Netherlands 73 8.0k 0.9× 3.4k 0.5× 5.4k 0.9× 2.9k 0.6× 3.4k 0.7× 378 25.2k
Thomas J. Smith United States 88 16.1k 1.8× 7.1k 1.1× 3.9k 0.7× 4.7k 0.9× 9.1k 1.9× 704 36.9k
Stuart R. Lipsitz United States 93 5.1k 0.6× 5.3k 0.8× 9.7k 1.7× 3.8k 0.7× 6.2k 1.3× 767 39.7k
Colin B. Begg United States 73 8.9k 1.0× 7.3k 1.1× 6.7k 1.2× 1.6k 0.3× 4.1k 0.9× 237 40.1k
Patrick Royston United Kingdom 84 4.3k 0.5× 5.1k 0.8× 6.3k 1.1× 5.2k 1.0× 5.5k 1.1× 269 51.5k
Stephen D. Walter Canada 96 3.9k 0.4× 5.1k 0.8× 6.2k 1.1× 7.8k 1.5× 3.5k 0.7× 451 43.7k
Neil K. Aaronson Netherlands 105 17.8k 2.0× 9.6k 1.5× 8.0k 1.4× 6.6k 1.3× 6.5k 1.3× 463 47.4k
Charles P. Quesenberry United States 100 8.1k 0.9× 5.7k 0.9× 5.0k 0.9× 2.7k 0.5× 4.1k 0.8× 517 33.0k

Countries citing papers authored by Peter Fayers

Since Specialization
Citations

This map shows the geographic impact of Peter Fayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fayers more than expected).

Fields of papers citing papers by Peter Fayers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Fayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fayers. The network helps show where Peter Fayers may publish in the future.

Co-authorship network of co-authors of Peter Fayers

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Fayers. A scholar is included among the top collaborators of Peter Fayers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Fayers. Peter Fayers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hays, Ron D., Peter Fayers, Andrew D. Auerbach, et al.. (2020). Do the unlabeled response categories of the Minnesota Living with Heart Failure Questionnaire satisfy the monotonicity assumption of simple-summated scoring?. Quality of Life Research. 29(5). 1349–1360. 4 indexed citations
2.
Hays, Ron D. & Peter Fayers. (2020). Overlap of Depressive Symptoms with Health-Related Quality-of-Life Measures. PharmacoEconomics. 39(6). 627–630. 25 indexed citations
3.
Nolte, Sandra, Gregor Liegl, Morten Aagaard Petersen, et al.. (2018). General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. European Journal of Cancer. 107. 153–163. 275 indexed citations breakdown →
4.
Brenne, Elisabeth, Jon Håvard Loge, Hanne C. Lie, et al.. (2016). The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer. Palliative Medicine. 30(6). 587–598. 10 indexed citations
5.
Wheelwright, Sally, Jane B. Hopkinson, Anne‐Sophie Darlington, et al.. (2016). Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With Cachexia. Journal of Pain and Symptom Management. 53(2). 232–242. 32 indexed citations
6.
Giesinger, Johannes M., Jacobien M. Kieffer, Peter Fayers, et al.. (2015). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology. 69. 79–88. 315 indexed citations breakdown →
7.
Paulsen, Ørnulf, Pål Klepstad, Jan Henrik Rosland, et al.. (2014). Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind Trial. Journal of Clinical Oncology. 32(29). 3221–3228. 130 indexed citations
8.
Costa, Daniel, Madeleine King, Neil K. Aaronson, et al.. (2014). The Development of Cancer-Specific Multi-Attribute Utility Instruments From the Eortc Qlq-C30 and Fact-G. Asia-Pacific Journal of Clinical Oncology. 10. 31–31. 1 indexed citations
9.
Fayers, Peter, Antonio Palumbo, Cyrille Hulin, et al.. (2011). Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials. Blood. 118(5). 1239–1247. 179 indexed citations
10.
Klepstad, Pål, Torill Fladvad, Frank Skorpen, et al.. (2011). Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients. Pain. 152(5). 1139–1145. 153 indexed citations
11.
Fayers, Peter. (2011). Alphas, betas and skewy distributions: two ways of getting the wrong answer. Advances in Health Sciences Education. 16(3). 291–296. 9 indexed citations
12.
Baxter, J., Peter Fayers, & Alastair McKinlay. (2006). A review of the quality of life of adult patients treated with long-term parenteral nutrition. Clinical Nutrition. 25(4). 543–553. 97 indexed citations
13.
Fayers, Peter & Ron D. Hays. (2005). Assessing quality of life in clinical trials : methods and practice. DigitalGeorgetown (Georgetown University Library). 197 indexed citations
14.
Grimshaw, Jeremy, et al.. (2003). Determinants of the intracluster correlation coefficient in cluster randomised trials. Controlled Clinical Trials. 24. 2 indexed citations
15.
Cuschieri, A., V Joypaul, Peter Fayers, et al.. (1996). Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer – results of the MRC randomised controlled trial. The Lancet. 347(9007). 995–999. 4 indexed citations
16.
Fayers, Peter. (1992). Quality-of-Life Assessment in Small Cell Lung Cancer. PharmacoEconomics. 2(3). 181–188. 4 indexed citations
17.
Talbot, I C, et al.. (1990). MRC Surgical Trial for Gastric Cancer: interim pathology results. Gut. 31(10). 1 indexed citations
18.
Fidler, Jack, Valerie Smith, Peter Fayers, & Michael de Swiet. (1983). Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.. BMJ. 286(6382). 1927–1930. 83 indexed citations
19.
Swiet, Michael de, Peter Fayers, & E A Shinebourne. (1976). Blood pressure survey in a population of newborn infants.. BMJ. 2(6026). 9–11. 53 indexed citations
20.
Spiers, A. S. D., Donald B. Calne, & Peter Fayers. (1970). Miosis during L-Dopa Therapy. BMJ. 2(5710). 639–640. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026